Avalo Therapeutics (AVTX) Shares Outstanding (Diluted) (2015 - 2026)
Avalo Therapeutics' Shares Outstanding (Diluted) came in at 20.11 million for Q2 2026, up 85.7% from 10.83 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Shares Outstanding (Diluted) (2015 - 2026) Analysis & Trends
For FY2025, Avalo Therapeutics' Shares Outstanding (Diluted) was 13.4 million, up 78.8% from FY2024.
- Shares Outstanding (Diluted) carries a five-year compound annual growth rate of 255.4% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Diluted) was 7.5 million in FY2024, 277,727 in FY2023 (+607.9%), 39,233 in FY2022 (+12.6%) and 34,836 in FY2021 (+47.3%).
- Year-over-year, Shares Outstanding (Diluted) has increased for five consecutive quarters, with growth averaging 65.4% over the last five quarters.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 12.4% (Q3 2022) and 607.9% (Q4 2023) over the last five years.
- Business Quant data shows AVTX's Shares Outstanding (Diluted) at 20.11 million (Q1 2026), 13.4 million (Q4 2025) and 14 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Avalo Therapeutics | 668.42 Mn | 668.42 Mn | - | 20.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.11 Mn |
| Mar 31, 2026 | 20.11 Mn |
| Dec 31, 2025 | 13.40 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 10.83 Mn |
| Mar 31, 2025 | 10.51 Mn |
| Dec 31, 2024 | 7.50 Mn |
| Sep 30, 2024 | 10.78 Mn |
| Jun 30, 2024 | 7.65 Mn |
| Mar 31, 2024 | 859,381.00 |
| Dec 31, 2023 | 277,727.00 |
| Sep 30, 2023 | 195,006.00 |
| Jun 30, 2023 | 58,263.00 |
| Mar 31, 2023 | 48,884.00 |
| Dec 31, 2022 | 39,233.00 |
| Sep 30, 2022 | 39,255.00 |
| Jun 30, 2022 | 39,202.00 |
| Mar 31, 2022 | 39,196.00 |
| Dec 31, 2021 | 34,836.00 |
| Sep 30, 2021 | 34,919.00 |
API Access
Avalo Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();